Litchfield Hills Initiates Coverage On SHL Telemedicine with Buy Rating, Announces Price Target of $11
Portfolio Pulse from Benzinga Newsdesk
Litchfield Hills analyst Theodore O'Neill initiates coverage on SHL Telemedicine (NASDAQ:SHLT) with a Buy rating and a price target of $11.
March 14, 2024 | 11:51 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Litchfield Hills has initiated coverage on SHL Telemedicine with a Buy rating and set a price target of $11.
The initiation of coverage by Litchfield Hills with a Buy rating and a price target significantly higher than the current trading price suggests a positive outlook for SHL Telemedicine's stock. This analyst endorsement can lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100